A Pharmacokinetic Study of TS-071 in Type 2 Diabetes Mellitus Patients With Renal Dysfunction
Latest Information Update: 25 May 2016
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Taisho Pharmaceutical
- 23 Sep 2011 New trial record
- 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.